Differential D 1 and D 5 Receptor Regulation and Degradation of the Angiotensin Type 1 Receptor
Authors:
- 1 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 51 (2) , 360-366
Abstract
Renal sodium transport is increased by the angiotensin type 1 receptor (AT 1 R), which is counterregulated by dopamine via unknown mechanisms involving either the dopamine type 1 (D 1 R) or dopamine type 5 receptor (D 5 R) that belong to the D 1 -like receptor family of dopamine receptors. We hypothesize that the D 1 R and D 5 R differentially regulate AT 1 R protein expression and signaling, which may have important implications in the pathogenesis of essential hypertension. D 1 R and D 5 R share the same agonists and antagonists; therefore, the selective effects of either D 1 R or D 5 R stimulation on AT 1 R expression in human renal proximal tubule cells were determined using antisense oligonucleotides selective to either D 1 R or D 5 R. We also determined the role of receptor tyrosine kinase and the proteosome on the D 1 R/D 5 R-mediated effects on AT 1 R expression and internalization. In renal proximal tubule cells, D 5 R (not D 1 R) decreased AT 1 R expression (half-life: 0.47±0.18 hours) and AT 1 R-mediated extracellular signal–regulated kinase 1/2 phosphorylation (232±18.9 U with angiotensin II [10 −7 mol/L] versus 81±8.9 U with angiotensin II [10 −7 mol/L] and fenoldopam [D 1 R/D 5 R agonist; 10 −6 mol/L; P 1 R expression was reversed by 4-amino-5-(4-chlorophenyl)-7-( t -butyl) pyrazolo (3,4-d) pyrimidine (c-Src tyrosine-kinase inhibitor) and clasto-lactacystin β-lactone (proteasome inhibitor), demonstrating that the fenoldopam-mediated decrease in total cell AT 1 R expression is a result of a c-Src- and proteasome-dependent process. D 5 R stimulation decreases AT 1 R expression and is c-Src and proteasome dependent. The discovery of differential regulation by D 1 R and D 5 R opens new avenues for the development of agonists selective to either receptor subtype as targeted antihypertensive agents that can decrease AT 1 R-mediated antinatriuresis.Keywords
This publication has 33 references indexed in Scilit:
- Mechanisms of Disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivityNature Clinical Practice Nephrology, 2006
- D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertensionKidney International, 2006
- Rat Strain Effects of AT 1 Receptor Activation on D 1 Dopamine Receptors in Immortalized Renal Proximal Tubule CellsHypertension, 2005
- The Sarcolemmal Calcium Pump Inhibits the Calcineurin/Nuclear Factor of Activated T-cell Pathway via Interaction with the Calcineurin A Catalytic SubunitJournal of Biological Chemistry, 2005
- Interaction of Angiotensin II Type 1 and D 5 Dopamine Receptors in Renal Proximal Tubule CellsHypertension, 2005
- Exploring type I angiotensin (AT1) receptor functions through gene targetingActa Physiologica Scandinavica, 2004
- Perturbation of D 1 Dopamine and AT 1 Receptor Interaction in Spontaneously Hypertensive RatsHypertension, 2003
- PKC‐ζ is required for angiotensin II‐induced activation of ERK and synthesis of C‐FOS in MCF‐7 cellsJournal of Cellular Physiology, 2003
- Dopamine D5 Receptor Agonist High Affinity and Constitutive Activity Profile Conferred by Carboxyl-terminal Tail SequenceJournal of Biological Chemistry, 2000
- Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats.Hypertension, 1990